Privigen 10% vial 100ML
Ended Awarded
- Contract number
- SPE2DB25FDK93
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,454
Award facts
- Contract value 100% obligated
- $17,454.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $17,454.00 for PRIVIGEN 10% vial 100ML under a firm fixed-price contract with the Defense Logistics Agency (DLA). The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 and valid through November 2026, known as the SPE2DB program, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
PRIVIGEN is an intravenous immunoglobulin (IVIG) therapy used for treating immune deficiencies and various immunological conditions across military health facilities. The delivery order to Park Ridge, Illinois reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. The company's consistent success in securing DLA contracts without set-aside designations demonstrates its competitive capability in federal procurement markets while serving as a direct distributor of prescription medications and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDK93?
SPE2DB25FDK93 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FDK93 worth?
The government has obligated $17,454 on SPE2DB25FDK93.
Is contract SPE2DB25FDK93 an order under another contract?
Yes. SPE2DB25FDK93 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK93 competed?
The extent of competition for SPE2DB25FDK93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award